A carregar...
Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers
Head and neck squamous cell carcinoma is the sixth most common cancer worldwide and despite advances in treatment over the last years, there is still a relapse rate of 50%. New therapeutic agents are awaited to increase the survival of patients. DNA repair targeted agents in combination with standar...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5655317/ https://ncbi.nlm.nih.gov/pubmed/29113422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20953 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|